
The Medicines and Healthcare products Regulatory Agency (MHRA) has put out a reminder for healthcare professionals and patients with asthma that overuse of blue inhalers (short-acting beta 2 agonists or SABAs), without use of a preventer inhaler, may lead to worsening symptoms or serious asthma a